JSE lifts on promising Covid-19 vaccine news

The JSE was firmer on Tuesday midday, as hopes about a successful early-stage trial of a coronavirus vaccine lifted investor sentiment, and prospects of more stimulus from major global economies added to global recovery optimism.

US biotechnology company Moderna has reported that a phase-1 trial of its coronavirus vaccine has shown promising results, showing signs that it can create an immune-system response to fend off the new coronavirus.

Source: businesslive.co.za